美好医疗1月26日获融资买入4868.64万元,融资余额3.19亿元

Core Viewpoint - On January 26, Meihao Medical experienced a decline of 5.46% in stock price, with a trading volume of 596 million yuan, indicating potential market volatility and investor sentiment concerns [1]. Financing Summary - On January 26, Meihao Medical had a financing buy-in amount of 48.69 million yuan and a financing repayment of 58.85 million yuan, resulting in a net financing outflow of 10.16 million yuan [1]. - The total financing and securities lending balance for Meihao Medical reached 321 million yuan, with the financing balance of 319 million yuan accounting for 1.74% of the circulating market value, indicating a high level compared to the past year [1]. - The securities lending activity on January 26 included a repayment of 1,800 shares and a sale of 2,400 shares, with a selling amount of 77,200 yuan, and a securities lending balance of 1.63 million yuan, also at a high level compared to the past year [1]. Company Overview - Meihao Medical, established on July 15, 2010, and listed on October 12, 2022, is located in Longgang District, Shenzhen, Guangdong Province, specializing in the design, development, manufacturing, and sales of medical device components [2]. - The company's revenue composition includes 59.48% from home respiratory device components, 14.61% from home and consumer electronics components, 10.33% from other medical product components, 8.16% from cochlear implant components, 5.63% from precision molds and automation equipment, and 0.70% from proprietary products [2]. Financial Performance - As of January 20, the number of shareholders for Meihao Medical was 29,600, a decrease of 30.08% from the previous period, while the average circulating shares per person increased by 43.02% to 12,618 shares [2]. - For the period from January to September 2025, Meihao Medical reported a revenue of 1.194 billion yuan, reflecting a year-on-year growth of 3.28%, while the net profit attributable to shareholders decreased by 19.25% to 208 million yuan [2]. Dividend and Shareholding - Since its A-share listing, Meihao Medical has distributed a total of 293 million yuan in dividends [3]. - As of September 30, 2025, the top ten circulating shareholders included notable funds such as Guotai Junan's value advantage flexible allocation fund and Huabao's medical ETF, with significant changes in holdings among various institutional investors [3].

Mehow Innovative -美好医疗1月26日获融资买入4868.64万元,融资余额3.19亿元 - Reportify